Table II.
Feature | A-RO | A-IRO | Value of p |
---|---|---|---|
ACT [points] | 12.4±1.7 | 13.2±1.4 | NS |
Oral steroid-free days [%] | 0 (0-0) 0±0 | 100 (0-100) 57±13 | – |
Symptom-free days [%] | 0 (0-0) | 0 (0-0) | – |
Days with diurnal PEF variability > 20% [%] | 6±4 | 19±8 | NS |
ESR [mm/h] | 6.8±1.6 | 10.2±2.5 | NS |
CRP | 2.2±0.5 | 6.3±2.6 | NS |
IgE total | 255.5±121.7 | 145.2±48.1 | NS |
Patients with positive specific IgE [%] | 83 | 58 | NS |
A-RO – asthma reversible obstruction subgroup, A-IRO – asthma irreversible obstruction subgroup, ACT – asthma control test, ACT – asthma control tests, ESR – erythrocyte sedimentation rate, CRP – C-reactive protein, IgE – immunoglobulin E